Reference

nuclear liver X receptor (LXR)-activating agents for skin treatment

nuclear liver X receptor (LXR)-activating agents for skin treatment. Gunn, David; Jenkins, Gail (Unilever PLC; Unilever NV; Hindustan Lever Limited, UK). PCT Int. Appl. WO 2004103376 A2 2 Dec 2004, 28 pp. 39025-24-6 is the cas registry number of certain chemical which is used as reagents here. DESIGNATED STATES: W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW; RW: AT, BE, BF, BJ, CF, CG, CH, CI, CM, CY, DE, DK, ES, FI, FR, GA, GB, GR, IE, IT, LU, MC, ML, MR, NE, NL, PT, SE, SN, TD, TG, TR. (English). (World Intellectual Property Organization). CODEN: PIXXD2. CLASS: ICM: A61K031-565. ICS: A61K031-566; A61K031-57; A61K031-575; A61P027-00; A61K007-48. APPLICATION: WO 2004-EP4944 6 May 2004. PRIORITY: GB 2003-11816 22 May 2003. DOCUMENT TYPE: Patent CA Section: 1 (Pharmacology) Section cross-reference(s): 2 A method is provided for enhancing decorin and/or fibronectin synthesis in the skin of an animal or human, comprising administering a nuclear liver X receptor (LXR)-activating agent. .